ViaDerma Inc (VDRM)

[Fasctrack]

I agree an RS at this price would be disastrous. If I were running the Company, assuming that the company cannot sustain itself from revenues, I would authorize another increase in the A/S. However, not all R/S' are a disaster. If the doctor can get the share price up to and hold around .40, then yeah maybe an R/S would work to get the stock above $2.00. At this price however, with no real recurring stream of revenues, an R/S would be a death knell.